Chemically distinct HDAC inhibitors prevent adipose conversion of subcutaneous human white preadipocytes at an early stage of the differentiation program

Experimental Cell Research

Volumn 315, Issue 19, 2009, Pages 3267-3280

  Catalioto, Rose Marie ^a   Maggi, Carlo Alberto ^a   Giuliani, Sandro ^a  

^a Menarini Ricerche SpA   (Italy)

Author keywords

Adipokines; Adipose conversion; Differentiation; HDAC inhibitor; Human subcutaneous preadipocytes; Proliferation

Indexed keywords

ALPHA TUBULIN; CCAAT ENHANCER BINDING PROTEIN ALPHA; FATTY ACID BINDING PROTEIN 4; FIBRONECTIN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HISTONE DEACETYLASE INHIBITOR; HISTONE H4; LACTATE DEHYDROGENASE; LEPTIN; N (2 AMINOPHENYL) 4 (3 PYRIDINYLMETHOXYCARBONYLAMINOMETHYL)BENZAMIDE; TRIACYLGLYCEROL; VALPROIC ACID; VASCULOTROPIN; VORINOSTAT;

ACETYLATION; ADIPOCYTE; ADIPOSE TISSUE CELL; ADULT; ARTICLE; CELL COUNT; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STRUCTURE; CELL VIABILITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DEVELOPMENTAL STAGE; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROBLAST; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; INHIBITION KINETICS; MALE; NICK END LABELING; PRIORITY JOURNAL; PROADIPOCYTE; PROTEIN EXPRESSION; PROTEIN SECRETION; WHITE ADIPOSE TISSUE;

EID: 70350375268     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2009.09.012     Document Type: Article

References (39)

1. Rosen E.D., and Spiegelman B.M. Adipocytes as regulators of energy balance and glucose homeostasis. Nature 444 (2006) 847-853
2. Berg A.H., and Scherer P.E. Adipose tissue, inflammation, and cardiovascular disease. Circ. Res. 96 (2005) 939-949
3. Fantuzzi G. Adipose tissue, adipokines, and inflammation. J. Allergy Clin. Immunol. 115 (2005) 911-919
4. Bays H.E., Gonzalez-Campoy J.M., Bray G.A., Kitabchi A.E., Bergman D.A., Schorr A.B., Rodbard H.W., and Henry R.R. Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity. Expert Rev. Cardiovasc. Ther. 6 (2008) 343-368
5. Smas C.M., and Sul H.S. Control of adipocyte differentiation. Biochem. J. 309 (1995) 697-710
6. Gregoire F.M., Smas C.M., and Sul H.S. Understanding adipocyte differentiation. Physiol. Rev. 78 (1998) 783-809
7. Claffey K.P., Wilkison W.O., and Spiegelman B.M. Vascular endothelial growth factor. Regulation by cell differentiation and activated second messenger pathways. J. Biol. Chem. 267 (1992) 16317-16322
8. De Ruijter A.J.M., Van Gennip A.H., Caron H.N., Kemp S., and Van Kuilenburg A.B.P. Histone deacetylases (HDACs): characterization of the classical HDAC family. Biochem. J. 370 (2003) 737-749
9. Bolden J.E., Peart M.J., and Johnstone R.W. Anticancer activities of histone deacetylase inhibitors. Nat. Rev., Drug Discov. 5 (2006) 769-784
10. Xu W.S., Parmigiani R.B., and Marks P.A. Histone deacetylase inhibitors: molecular mechanisms of action. Oncogene 26 (2007) 5541-5552
11. Henkens T., Papeleu P., Elaut G., Vinken M., Rogiers V., and Vanhaecke T. Trichostatin A, a critical factor in maintaining the functional differentiation of primary cultured rat hepatocytes. Toxicol. Appl. Pharmacol. 218 (2007) 64-71
12. Haumaitre C., Lenoir O., and Scharfmann R. Histone deacetylase inhibitors modify pancreatic cell fate determination and amplify endocrine progenitors. Mol. Cell. Biol. 28 (2008) 6373-6383
13. Tou L., Liu Q., and Shivdasani R.A. Regulation of mammalian epithelial differentiation and intestine development by class I histone deacetylases. Mol. Cell. Biol. 24 (2004) 3132-3139
14. Rahman M., Kukita A., Kukita T., Shobuike T., Nakamura T., and Kohashi O. Two histone deacetylase inhibitors, trichostatin A and sodium butyrate, suppress differentiation into osteoclasts but not into macrophages. Blood 101 (2003) 3451-3459
15. Burton G.R., Nagarajan R., Peterson C.A., and McGehee R.E. Microarray analysis of differentiation-specific gene expression during 3T3-L1 adipogenesis. Gene 31 (2004) 167-185
16. Lagace D.C., and Nachtigal M.W. Inhibition of histone deacetylase activity by valproic acid blocks adipogenesis. J. Biol. Chem. 279 (2004) 18851-18860
17. Yoo E.J., Chung J.-J., Choe S.S., Kim K.H., and Kim J.B. Down-regulation of histone deacetylases stimulates adipocyte differentiation. J. Biol. Chem. 281 (2006) 6608-6615
18. Lee J.H. Diallyl disulfide accelerates adipogenesis in 3T3-L1 cells. Int. J. Mol. Med. 20 (2007) 59-64
19. Khan N., Jeffers M., Kumar S., Hackett C., Boldog F., Khramtsov N., Qian X., Mills E., Berghs S.C., Carey N., Finn P.W., Collins L.S., Tumber A., Ritchie J.W., Jensen P.B., Lichenstein H.S., and Sehested M. Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors. Biochem. J. 409 (2008) 581-589
20. Chung S., LaPoint K., Martinez K., Kennedy A., Sandberg M.B., and McIntosh M.K. Preadipocytes mediate LPS-induced inflammation and insulin resistance in primary cultures of newly differentiated human adipocytes. Endocrinology 147 (2006) 5340-5351
21. Armeanu S., Pathil A., Venturelli S., Mascagni P., Weiss T.S., Gottlicher M., Gregor M., Lauer U.M., and Bitzer M. Apoptosis on hepatoma cells but not on primary hepatocytes by histone deacetylase inhibitors valproate and ITF2357. J. Hepatol. 42 (2005) 210-217
22. Atadja P., Gao L., Kwon P., Trogani N., Walker H., Hsu M., Yeleswarapu L., Chandramouli N., Perez L., Versace R., Wu A., Sambucetti L., Lassota P., Cohen D., Bair K., Wood A., and Remiszewski S. Selective growth inhibition of tumor cells by a novel histone deacetylase inhibitor, NVP-LAQ824. Cancer Res. 64 (2004) 689-695
23. Hsieh J., Nakashima K., Kuwabara T., Mejia E., and Gage F.H. Histone deacetylase inhibition-mediated neuronal differentiation of multipotent adult neural progenitor cells. P.N.A.S. 101 (2004) 16659-16664
24. Chen T.-H., Chen W.-M., Hsu K.-H., Kuo C.-D., and Hung S.-C. Sodium butyrate activates ERK to regulate differentiation of mesenchymal stem cells. Biochem. Biophys. Res. Commun. 355 (2007) 913-918
25. Catalano M.G., Poli R., Pugliese M., Fortunati N., and Boccuzzi G. Valproic acid enhances tubulin acetylation and apoptotic activity of paclitaxel on anaplastic thyroid cancer cell lines. Endocr.-Relat. Cancer 14 (2007) 839-845
26. Papeleu P., Vanhaecke T., Elaut G., Vinken M., Henkens T., Snykers S., and Rogiers V. Differential effects of histone deacetylase inhibitors in tumor and normal cells-what is the toxicological relevance?. Crit. Rev. Toxicol. 35 (2005) 363-378
27. Huber Lars C., Distler J.H.W., Moritz F., Hemmatazad H., Hauser T., Michel B.A., Gay R.E., Matucci-Cerinic M., Gay S., Distler O., and Jüngel A. Trichostatin A prevents the accumulation of extracellular matrix in a mouse model of bleomycin-induced skin fibrosis. Arthritis Rheum. 56 (2007) 2755-2764
28. Wiper-Bergeron N., Wu D., Pope L., Schild-Poulter C., and Haché R.J.G. Stimulation of preadipocyte differentiation by steroid through targeting of an HDAC1 complex. EMBO J. 22 (2003) 2135-2145
29. Tchkonia T., Giorgadze N., Pirtskhalava T., Tchoukalova Y., Karagiannides I., Forse R.A., DePonte M., Stevenson M., Guo W., Han J., Waloga G., Lash T.L., Jensen M.D., and Kirkland J.L. Fat depot origin affects adipogenesis in primary cultured and cloned human preadipocytes. Am. J. Physiol., Regul. Integr. Comp. Physiol. 282 (2002) R1286-R1296
30. Fajas L., Egler V., Reiter R., Hansen J., Kristiansen K., Debril M.-B., Miard S., and Auwerx J. The retinoblastoma-histone deacetylase 3 complex inhibits PPARγ and adipocyte differentiation. Dev. Cell 3 (2002) 903-910
31. Toscani A., Soprano D.R., and Soprano K.J. Sodium butyrate in combination with insulin or dexamethasone can terminally differentiate actively proliferating Swiss 3T3 cells into adipocytes. J. Biol. Chem. 265 (1990) 5722-5730
32. Kim S.N., Choi H.Y., and Kim Y.K. Regulation of adipocyte differentiation by histone deacetylase inhibitors. Arch. Pharm. Res. 32 (2009) 535-541
33. Entenmann G., and Hauner H. Relationship between replication and differentiation in cultured human adipocyte precursor cells. Am. J. Physiol. 270 (1996) C1011-C1016
34. Yeh W.-C., Cao Z., Classon M., and McKnight S.L. Cascade regulation of terminal adipocyte differentiation by three members of the C/EBP family of leucine zipper proteins. Genes Dev. 9 (1995) 168-181
35. Tomlinson J.J., Boudreau A., Wu D., Atlas E., and Haché R.J.G. Modulation of early human preadipocyte differentiation by glucocorticoids. Endocrinology 147 (2006) 5284-5293
36. Steppan C.M., Bailey S.T., Bhat S., Brown E.J., Banerjee R.R., Wright C.M., Patel H.R., Ahima R.S., and Lazar M.A. The hormone resistin links obesity to diabetes. Nature 409 (2001) 307-312
37. Janke J., Engeli S., Gorzelniak K., Luft F.C., and Sharma A.M. Resistin gene expression in human adipocytes is not related to insulin resistance. Obes. Res. 10 (2002) 1-5
38. Kroenke C.H., Chen W.Y., Rosner B., and Holmes M.D. Weight, weight gain, and survival after breast cancer diagnosis. J. Clin. Oncol. 23 (2005) 1370-1378
39. Calle E.E., Rodriguez C., Walker-Thurmond K., and Thun M.J. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N. Engl. J. Med. 348 (2003) 1625-1638